SciClone Pharmaceuticals, Inc. misses by $0.07, misses on revenue

SciClone Pharmaceuticals, Inc. (SCLN): Q4 EPS of $0.08 misses by $0.07.

Revenue of $32.73M (-1.2% Y/Y) misses by $5.57M.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs